TABLE 14

Results of regression analyses for costs and QALYs: subgroup analysis by sex

SexCoefficient95% CIp-valueMarginal effect
Female (n = 330) Total cost of hospital stay
Intervention arm−0.050−0.237 to 0.1370.600−864
Total cost for blood products
Intervention arm0.201−0.031 to 0.4320.089365
Total cost
Intervention arm−0.026−0.204 to 0.1520.773−500
QALYs (without imputation) a
Intervention arm0.0003−0.0026 to 0.00310.862
QALYs (with imputation)
Intervention arm0.001−0.001 to 0.0040.361
Male (n = 1251) Total cost of hospital stay
Intervention arm−0.009−0.116 to 0.0980.866−161
Total cost for blood products
Intervention arm0.2960.166 to 0.455< 0.01560
Total cost
Intervention arm0.206−0.070 to 0.1110.656399
QALYs (without imputation) b
Intervention arm−0.0001−0.0019 to 0.00170.912
QALYs (with imputation)
Intervention arm−0.001−0.002 to 0.0010.238
a

n = 248.

b

n = 813.

From: Chapter 4, Economic evaluation

Cover of Early high-dose cryoprecipitate to reduce mortality in adult patients with traumatic haemorrhage: the CRYOSTAT-2 RCT with cost-effectiveness analysis
Early high-dose cryoprecipitate to reduce mortality in adult patients with traumatic haemorrhage: the CRYOSTAT-2 RCT with cost-effectiveness analysis.
Health Technology Assessment, No. 28.76.
Curry N, Davenport R, Thomas H, et al.
Copyright © 2024 Curry et al.

This work was produced by Curry et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This is an Open Access publication distributed under the terms of the Creative Commons Attribution CC BY 4.0 licence, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. See: https://creativecommons.org/licenses/by/4.0/. For attribution the title, original author(s), the publication source – NIHR Journals Library, and the DOI of the publication must be cited.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.